PMID- 15521010 OWN - NLM STAT- MEDLINE DCOM- 20041203 LR - 20190707 IS - 0016-5085 (Print) IS - 0016-5085 (Linking) VI - 127 IP - 5 DP - 2004 Nov TI - hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. PG - 1401-9 AB - BACKGROUND AND AIMS: Bacterial proteoglycan-derived muramyl dipeptide (MDP) activates the intracellular NOD2/CARD15 gene product. How intestinal epithelial cells take up MDP is poorly understood. We hypothesized that the intestinal apical di-/tripeptide transporter, hPepT1, transports MDP, thereby activating downstream pathways similar to nuclear factor kappa B (NF-kappaB). METHODS: Time- and concentration-dependent (3)H-MDP uptakes were studied in Caco2/bbe (C2) cell monolayers where hPepT1 expression was either over- or underexpressed, using an inducible adenovirus system or silencing RNA (siRNA), respectively. NF-kappaB activation and interleukin (IL)-8 and monocyte chemoattractant protein-1 (MCP-1) release were determined by enzyme-linked immunosorbent assay. NOD2/CARD15 expression was inhibited by siRNA. MDP in human duodenal, cecal, and stool samples was measured. RESULTS: MDP, but not its isoforms, inhibited uptake of glycosylsarcosine in C2 cells, indicating stereoselective and competitive inhibition. Approximately 90% of the MDP was cytosolic, showing uptake rather than binding. The K m for MDP uptake was 4.3 mmol/L. Cells overexpressing hPepT1 showed increased Gly-Sar and MDP uptake, whereas decreased uptake was observed after hPepT1 siRNA-inhibition. MDP treatment activated NF-kappaB, resulting in IL-8 release, an effect blocked by siRNA-inhibited expression of NOD2/CARD15. MDP content in cecal and stool samples (in normal subjects) was 20-87 micromol/L, but undetectable in duodenal fluid. CONCLUSIONS: In colonic epithelial cells, MDP is taken up by hPepT1 and activates NF-kappaB and chemokine production. Because hPepT1 expression in chronic colonic inflammation is increased, this may play an important role in promoting colonocyte participation in host defense and pathogen clearance through increased uptake of MDP. FAU - Vavricka, Stephan R AU - Vavricka SR AD - IBD Research Center, University of Chicago, Chicago, IL 60637, USA. FAU - Musch, Mark W AU - Musch MW FAU - Chang, Jonathan E AU - Chang JE FAU - Nakagawa, Yasushi AU - Nakagawa Y FAU - Phanvijhitsiri, Kittiporn AU - Phanvijhitsiri K FAU - Waypa, Tonya S AU - Waypa TS FAU - Merlin, Didier AU - Merlin D FAU - Schneewind, Olaf AU - Schneewind O FAU - Chang, Eugene B AU - Chang EB LA - eng GR - DK-061941/DK/NIDDK NIH HHS/United States GR - DK-38510/DK/NIDDK NIH HHS/United States GR - DK-42086/DK/NIDDK NIH HHS/United States GR - DK-47722/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Gastroenterology JT - Gastroenterology JID - 0374630 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) RN - 0 (Peptide Fragments) RN - 0 (Peptide Transporter 1) RN - 0 (RNA, Small Interfering) RN - 0 (SLC15A1 protein, human) RN - 0 (Symporters) RN - 53678-77-6 (Acetylmuramyl-Alanyl-Isoglutamine) SB - IM MH - Acetylmuramyl-Alanyl-Isoglutamine/*metabolism MH - Amino Acid Sequence MH - Biological Transport MH - Cell Line, Tumor MH - Chemokine CCL2/metabolism MH - Colonic Neoplasms MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Interleukin-8/*metabolism MH - Intestinal Mucosa MH - Molecular Sequence Data MH - NF-kappa B/*metabolism MH - Peptide Fragments/chemistry MH - Peptide Transporter 1 MH - RNA, Small Interfering/genetics MH - Symporters/*genetics/metabolism EDAT- 2004/11/03 09:00 MHDA- 2004/12/16 09:00 CRDT- 2004/11/03 09:00 PHST- 2004/11/03 09:00 [pubmed] PHST- 2004/12/16 09:00 [medline] PHST- 2004/11/03 09:00 [entrez] AID - S0016508504013320 [pii] AID - 10.1053/j.gastro.2004.07.024 [doi] PST - ppublish SO - Gastroenterology. 2004 Nov;127(5):1401-9. doi: 10.1053/j.gastro.2004.07.024.